Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02302742 · ClinicalTrials.gov registry record

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

A clinical trial of Breast Cancer and Hereditary Breast and Ovarian Cancer, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
1,500
Enrollment target
11
Study locations

NCT02302742 is a study of Breast Cancer and Hereditary Breast and Ovarian Cancer that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 1,500 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (46% lower). The trial reports 11 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02302742, a study of Breast Cancer and Hereditary Breast and Ovarian Cancer, is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
1,500 participants
Enrollment target
11
Study locations

Study Summary

PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).

Conditions Studied

Breast Cancer Hereditary Breast and Ovarian Cancer

Study Locations (11)

Kansas

  • Hays Medical Center Dreiling-Schmidt Cancer Institute - Hays
  • KCCC West - Kansas City
  • KCCC Overland Park - Overland Park
  • Overland Park Regional Medical Center - Overland Park
  • Salina Regional Health Center - Tammy Walker Cancer Center - Salina
  • The University of Kansas Cancer Center - Westwood

Missouri

  • Universtiy Health - Kansas City
  • KCCC South - Kansas City
  • Research Medical Center - Kansas City
  • KCCC - North - Kansas City
  • KCCC Lee's Summit - Lee's Summit

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2011-03-22
Est. Completion 2026-12

Sponsor

University of Kansas Medical Center

408 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02302742

The ClinicalTrials.gov registry entry for NCT02302742 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (46% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT02302742 reports 11 study locations spanning 2 distinct geographic areas - top geographies include Kansas, Missouri.

Frequently Asked Questions

What is clinical trial NCT02302742 about?

NCT02302742 is a clinical study titled "Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry". PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).

What is the current status of trial NCT02302742?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2011-03-22. Estimated completion is 2026-12.

What conditions does trial NCT02302742 study?

This clinical trial studies the following conditions: Breast Cancer, Hereditary Breast and Ovarian Cancer.

Who is sponsoring clinical trial NCT02302742?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02302742 being conducted?

This trial has 11 study locations across Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Hereditary Breast and Ovarian Cancer

All registered trials for this condition

Kansas

All trials with a study site in Kansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.